Clinical Trial Update: Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing maraviroc versus etravirine in combination antiretroviral therapy for drug-experienced HIV patients co-infected with hepatitis B or C …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B
• Hepatitis C

Drugs mentioned

• Maraviroc (maraviroc)
• etravirine (etravirine)

Snippet

Sponsor: ViiV Healthcare | Conditions: Hepatitis B, Human Immunodeficiency Virus | Phase 4 | Status: WITHDRAWN